openPR Logo
Press release

Medical Morphine Market Outlook 2020 to 2023 Key Surgical Methods and Unique Types of Application Arthritis, Cancer, Kidney Stones

12-11-2020 05:02 AM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
Medical Morphine Market Information by Route of Administration Oral, Injectables Application Arthritis, Cancer, Kidney Stones, Distribution Channel Hospital Pharmacy, Online Pharmacy, and End-User Hospitals & Clinics – Global Forecast Till 2023

Market Segmentation

In MRFR’s report, the Medical Morphine Market is segmented on the basis of administration, application, distribution channel and end-users.

Based on administration, it is segmented into injectable and oral. Here the oral segment is predicted to have maximum market share due to its high accessibility, dose accuracy and the ease of carrying the same in comparison to injectables as well as other counterparts.

Based on application, the medical morphine market is segmented into diarrhea, myocardial infarction, kidney stone, cancer and arthritis and others. Of all, the others segment is predicted to grow at the fastest with 3.1% CAGR due to rising number of morphine prescriptions for nominal conditions in the US. The cancer segment is predicted to touch a lucrative growth during the forecast period owing to rising prevalence of bone cancer across the world.

Based on distribution channel, it is segmented into online pharmacy, retail pharmacy and hospital pharmacy.

Based on end-users, the medical morphine market is segmented into homecare, ambulatory surgical centers, hospitals and clinics.

Request Free Sample Report At https://www.marketresearchfuture.com/sample_request/6084

Market Players

Mallinckrodt Pharmaceuticals
Alcaliber S.A
Purdue Pharma L.P.
Pfizer Inc.
Johnson Matthey Fine Chemicals
Sun Pharmaceutical Industries Ltd.
Verve Health Care Ltd.
Taj Pharmaceuticals Limited
NORTHEAST PHARM
MANUS AKTTEVA BIOPHARMA LL
Medical Morphine Market - Market Analysis

Morphine is basically a quintessential pain medication prescribed by licensed physicians. It belongs to the group of painkillers known as opioids which acts on the central nervous system directly to reduce chronic and acute pain. Today, it is taken in different forms namely oral solutions, injections, tablets and capsules and suppositories. Morphine is a strong painkiller that is used for treating severe pain such as during a serious injury, post operation or pain from a heart attack or cancer. Moreover, it is also used in case of other types of pain that are long-standing where weaker painkillers fail to work. The dosage of morphine differs from individual to individual and will rest on the severity of the pain. It is available in two forms- slow-release morphine and fast-acting morphine.

Competitive Analysis

The rising number of investors in this market is strengthening the competition amid the global medical morphine market players. The high expenditure on R&D by the pharmaceutical companies to introduce new products in the global market along with strategic mergers and acquisition by the leading players is resulting in the expansion of their business within the medical morphine market.

Regional Analysis

Based on region, the medical morphine market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America leads the market due to rising demand for opioid pain medications. Europe holds the second largest position due to rising prevalence of diseases such as myocardial infarction, cancer and others. In Asia Pacific, the medical morphine market is projecting a striking growth owing to rising geriatric population combined with increased intake of medical morphine as a pain killer in this region. The medical morphine market in Middle East and Africa is predicted to grow in a steady pace owing to limited accessibility of medical facilities, lack of awareness amid the people in the region’s underdeveloped areas and poor healthcare infrastructure.

BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 62 RESPECTIVE TABLES AND FIGURES AT https://www.marketresearchfuture.com/reports/medical-morphine-market-6084

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Medical Morphine Market Outlook 2020 to 2023 Key Surgical Methods and Unique Types of Application Arthritis, Cancer, Kidney Stones here

News-ID: 2207244 • Views:

More Releases from Market Research Future

Salicylic Acid Market Analysis: Industry Growth at a 7.0% CAGR During 2026-2035
Salicylic Acid Market Analysis: Industry Growth at a 7.0% CAGR During 2026-2035
The global salicylic acid market is experiencing robust growth, driven by its essential role in dermatology, cosmetics, and pharmaceutical applications. According to a comprehensive report by Market Research Future, the market was valued at USD 130.12 million in 2025 and is projected to reach USD 254.83 million by 2035, advancing at a compound annual growth rate of 7.0%. This expansion reflects the compound's established regulatory status, increasing consumer demand for
Specialty Silica Market Set for Steady Growth, Surpassing USD 8,893 Million by 2035
Specialty Silica Market Set for Steady Growth, Surpassing USD 8,893 Million by 2 …
The global specialty silica market is experiencing steady growth, driven by its indispensable role in high-performance applications ranging from green tires to semiconductor manufacturing. According to a comprehensive report by Market Research Future, the market was valued at USD 5,920 million in 2025 and is projected to reach USD 8,893 million by 2035, advancing at a compound annual growth rate of 4.15%. This trajectory reflects a structural shift in industrial
Lubricant Additives Market Outlook: Capitalising on High-Performance Formulations through 2035
Lubricant Additives Market Outlook: Capitalising on High-Performance Formulation …
The global lubricant additives market is navigating a period of profound transformation, driven by tightening emissions regulations, the rise of electric vehicles, and a relentless push for greater fuel efficiency. According to a comprehensive report by Market Research Future, the market was valued at USD 19.55 billion in 2025 and is projected to reach USD 27.71 billion by 2035, advancing at a compound annual growth rate of 3.55%. This growth
Emulsion Polymers Market: Navigating the Shift Toward Sustainable, High-Performance Solutions
Emulsion Polymers Market: Navigating the Shift Toward Sustainable, High-Performa …
The global emulsion polymers market is on a steady growth trajectory, driven by a powerful combination of environmental regulations, technological innovation, and large-scale infrastructure investment. According to a comprehensive report by Market Research Future, the market was valued at USD 31.15 billion in 2025 and is projected to reach USD 54.98 billion by 2035, reflecting a compound annual growth rate of 5.85%. This expansion is primarily fueled by the accelerating

All 5 Releases


More Releases for Pharma

Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring